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We review the contemporary understanding of the pathophysiology of repolarization
alternans and present a perspective on the use of T-wave alternans (TWA) as a risk
stratification marker of malignant ventricular arrhythmias. Several studies have demonstrated
a high correlation of susceptibility to ventricular arrhythmias and sudden cardiac death with
the existence of TWA. We describe a number of cellular and molecular alterations in the
diseased heart that may provide a link between electrical and mechanical alternans and
arrhythmia susceptibility. Repolarization alternans is likely the result of distinct and diverse
cellular and molecular alterations that are associated with exaggerated regional repolarization
heterogeneity, which renders the heart susceptible to malignant arrhythmias. (J Am Coll
Cardiol 2002;40:207–17) © 2002 by the American College of Cardiology Foundation
Sudden cardiac death (SCD) remains a major challenge in
developed countries; it accounts for 11% of all deaths and
approximately 50% of all cardiovascular deaths (1). In the
U.S. alone, nearly 300,000 patients (1 to 2 per 1,000
population) experience SCD (2). The vast majority of these
cases are due to ventricular tachycardia (VT) or ventricular
fibrillation (VF). Over the past two decades, tremendous
progress has been made in the development of therapeutic
modalities, such as the implantable cardioverter-defibrillator
(ICD); however, similar progress in identifying patients at
high risk has lagged behind. Large multicenter studies, such
as the Multicenter Automatic Defibrillator Implantation
Trial and the Multicenter Unsustained Tachycardia Trial
(MUSTT), suggested that electrophysiologic (EPS) testing
may be useful in identifying patients who would benefit
from ICD therapy (3,4). The MUSTT suggested that EPS
testing alone was not sensitive enough to identify broader
groups of patients at risk for SCD (4). Moreover, noninva-
sive markers of risk-stratification, such as left ventricular
ejection fraction (LVEF), frequent ventricular premature
complexes and ventricular late potentials (LP), though
sensitive, suffer from low specificity and positive predictive
value (5,6). Determination of heart rate variability (HRV),
especially in combination with LVEF, ventricular prema-
ture complexes and LP, has significantly improved risk
prediction, but its positive predictive accuracy remains low
(6).
The preceding discussion underscores the need for a
screening procedure that is more sensitive and specific, with
a higher predictive power for identifying patients at high
risk of developing VT/VF. Recently, assessment of repolar-
ization alternans (T-wave alternans [TWA]) in the electro-
cardiogram (ECG) has been suggested as a predictor of
susceptibility to malignant ventricular arrhythmias (7–9).
The TWA is characterized by changes in contour, ampli-
tude or polarity of the T-wave, appearing with regular
rhythmicity, usually every other beat, unaccompanied by
gross changes in the cycle length.
This review discusses what is known about the cellular
basis of cardiac (electrical and mechanical) alternans and the
clinical relevance of repolarization alternans, with special
reference to its prognostic efficacy in predicting arrhythmia
susceptibility.
HISTORY OF CARDIAC ALTERNANS
Cardiac alternans has been divided into two general cate-
gories: electrical and mechanical; electrical alternans arises
from a fundamental change in the electrical conduction
pattern of the myocardium, and mechanical alternans arises
from an alternation of the mechanical activity of the heart.
Electrical alternans is a pattern of variation in the shape of
ECG waveform that appears on an every-other-beat basis
(10–21). Electrocardiographic alternans was first described
in 1908 by Hering (10). Shortly thereafter, Thomas Lewis
(11) recognized that cardiac alternans could occur in normal
hearts as a result of marked acceleration of heart rate and
also in the impaired or intoxicated myocardium. In 1948,
Kalter and Schwartz (12) reviewed clinical ECGs from
6,059 patients and found five cases of macroscopically
visible TWA, a frequency of 0.08%. Probably because of the
very low incidence of visible TWA, it remained nothing
more than an ECG curiosity for many decades.
In humans, visible (macroscopic) alternation in ventricu-
lar repolarization has been associated with increased vulner-
ability to ventricular arrhythmias under diverse pathophys-
iologic conditions (both experimental and clinical) such as
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myocardial ischemia (13–20), Prinzmetal’s angina (21,22),
states of altered autonomic tone (15,16,23,24), electrolyte
abnormalities (22,25) and the long QT syndrome (26–28).
Microscopic TWA was first reported in 1982 (29).
Subsequently, various studies have led to the development
of the fast Fourier Transform (FFT) spectral method to
detect microvolt-level TWA and the establishment of a
relationship between TWA and VF threshold in animal
studies and susceptibility to ventricular arrhythmias in
humans undergoing EPS testing (30–32).
PATHOPHYSIOLOGY OF CARDIAC ALTERNANS
Ionic currents, calcium homeostasis and alternans.
Several lines of evidence suggest that electromechanical
alternans is linked to alterations in cellular Ca2 homeosta-
sis (33). Calcium homeostasis is not only important for
excitation-contraction coupling but it also significantly in-
fluences the action potential (AP) profile and duration
(APD). Excitation leads to the opening of voltage-gated
L-type Ca2 channels, allowing the entry of a small amount
of Ca2 into the cell. The small amount of Ca2 that enters
the cell through the L-type Ca2 channel triggers a larger
release of Ca2 from the sarcoplasmic reticulum (SR) via
Ca2 release channels or ryanodine receptors (so-called
calcium-induced calcium release), activating the myofila-
ments and leading to contraction. During relaxation, Ca2
is sequestered in the SR by the SR Ca2 adenosine
triphosphatase and extruded from the cell by the sodium
calcium exchanger. The change in intracellular Ca2 during
the cardiac cycle or calcium transient has direct and indirect
effects on a number of ionic currents in ventricular myo-
cytes, and therefore on the APD and profile. In addition to
the profound effects on myocyte repolarization, intracellular
Ca2 influences cell-to-cell coupling and, thus, conduction
of electrical impulses in the heart.
Altered electrophysiology of the heart or electrical re-
modeling is a recurring feature of myocardial failure, which
has been associated with an increased risk of arrhythmic
death (34). Furthermore, both electrical and mechanical
alternans are easier to elicit by rapid pacing in animals with
heart failure (35,36). This arrhythmogenic substrate is the
result of a change in the functional expression of proteins
responsible for repolarizing currents and Ca2 homeostasis
in the failing heart.
Both a concordant and discordant relationship between
alternation of the calcium transient (and strength of con-
traction) and APD has been observed (37). Although the
precise cellular mechanism of alternans either concordant or
discordant is not established, it has been suggested that
altered restitution of the calcium transient, a multistep
process involving Ca2 uptake into the SR, redistribution in
the SR and release through the ryanodine receptor, may
underlie alternans. Furthermore, an indication that electrical
and mechanical alternans are mechanistically linked was
provided by Orchard et al. (38), who observed mechanical
alternans in voltage-clamped isolated myocytes, suggesting
that AP alternans was rather due to calcium-transient
alternans and not vice versa.
The profound cellular metabolic disturbances in ischemic
hearts almost certainly play a role in the induction of
mechanical and electrical alternans. In support of a theory
that links the occurrence of cardiac alternans to decreased
energy availability in the ischemic cell, Hu¨ser et al. (39)
suggest that the occurrence of alternans may be associated
with the inhibition of adenosine triphosphate (ATP) pro-
duction, thus affecting excitation-contraction coupling, per-
haps on an every-other-beat basis.
Potassium channels may also play an important role in
ischemia-induced TWA. The different spatial (epicardial vs.
endocardial) sensitivity of KATP channel activation during
ischemia (40) may be linked to repolarization alternans at
the cellular level during regional ischemia (41–43). In a
porcine model, acute ischemia shortened the APD and
decreased the AP amplitude, velocity of depolarization and
resting membrane potential. Alternans of AP amplitude was
associated with alternation of ST segment, and alternans of
upstroke velocity of the AP was associated with alternating
QRS morphology (42).
Connexins are integral membrane ion channel proteins
that govern cell-to-cell communication and conduction.
Cellular uncoupling in hypoxia and ischemia has been
shown to occur concomitantly with the onset of ischemic
contracture (44), an increase in free cytoplasmic Ca2
(44,45), rapid depletion of ATP (46) and acidification (47).
This indicates that both depressed excitability and cellular
uncoupling are likely to be inhomogeneous within an
ischemic region and may contribute inhomogeneous im-
pulse propagation, leading to excitation of alternating pop-
Abbreviations and Acronyms
AP  action potential
APD  action potential duration
DCM  dilated cardiomyopathy
ECG  electrocardiogram
EPS  electrophysiologic
FFT  fast Fourier Transform
HCM  hypertrophic cardiomyopathy
HRV  heart rate variability
ICD  implantable cardioverter-defibrillator
k  alternans ratio
LP  late potentials
LVEF  left ventricular ejection fraction
MI  myocardial infarction
MUSTT  Multicenter Unsustained Tachycardia Trial
NSVT  nonsustained ventricular tachycardia
RR  relative risk
SAECG  signal-averaged electrocardiography
SCD  sudden cardiac death
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TWA  T-wave alternans
Valt  alternans magnitude
VF  ventricular fibrillation
VT  ventricular tachycardia
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ulations of cells or to alternation in the response to activa-
tion of individual cells. In support of this hypothesis,
Pastore and Rosenbaum (48) have shown that electrotonic
uncoupling of cells promotes the development of discordant
alternans (for definition see Table 1), which in turn pro-
motes marked gradients of repolarization and a substrate for
functional re-entry.
In the failing human heart a decrease in the beta-
adrenergic, activation-mediated protein phosphorylation of
contractile proteins has been observed (49,50). A logical
extension of such a case is the development of mechanical
alternans. For example, reduced phosphorylation of cardiac
troponin I, which leads to an increased affinity of troponin
C for Ca2 and thus an increased Ca2 sensitivity of force
development, could represent a link between the cytoplas-
mic Ca2 (calcium transient) and mechanical alternans in
the cardiac myocyte (51).
Repolarization alternans and arrhythmogenesis.
Whether TWA is solely an effect or a cause linked to
arrhythmogenesis has been an intriguing question. In both
animal experiments and computer simulations (29,32) the
presence of TWA is consistently associated with an in-
creased susceptibility to VT/VF; thus, it has been hypoth-
esized that, in addition to being a marker of vulnerability to
ventricular tachyarrhythmias, TWA per se might be ar-
rhythmogenic.
Suggested mechanisms of electrical alternans include
excitation of alternating populations of cells in sequential
beats (52), alternation of the AP waveform (53) and global
movement of the heart within the chest (54). The proposed
mechanisms of mechanical alternans include alternation of
the loading of the heart (55), alternation in the contractile
state of the heart through alternation in the number of cells
involved in systole (56), or alternation in the strength of
contraction of each cell (51).
Currently, there are two prevailing and closely linked
hypotheses regarding the arrhythmogenic mechanisms as-
sociated with TWA. One is based on the concept that
prolongation of repolarization favors re-entry when the
prolongation is heterogeneous and dispersion of refractori-
ness is significantly enhanced (57). This dispersion-of-
refractoriness hypothesis states that intrinsic dispersion of
ventricular refractoriness prevents myocytes with the longest
recovery times from depolarizing, or from depolarizing
completely, every other cycle, resulting in a 2:1 behavior on
the surface ECG. As a consequence, the resulting inhomo-
geneity in dispersion of recovery may lead to myocardial
areas exhibiting prolonged recovery providing evanescent
barriers to conduction (i.e., unidirectional block), which
facilitate wavefront fractionation and reentry. Indeed, com-
puter simulations using finite-element models have shown
that with sufficient intrinsic dispersion of refractoriness
some areas of the myocardium depolarize only partially
every other beat (58), leading to repolarization alternans in
the simulated surface ECG. Experimental support for this
hypothesis is provided in ischemia models in which ECG
alternans during regional ischemia was generated by alter-
nating conduction block into the ischemic zone. In hyper-
trophic cardiomyopathy, which constitutes another form of
structural heart disease, myocardial fiber disarray alone—
which decreases cell-to-cell coupling and increases intraven-
tricular conduction abnormalities—could lead to exagger-
ated dispersion of refractoriness and of conduction
properties that could facilitate the occurrence of TWA and
thus become a potential arrhythmogenic mechanism (59).
The second hypothesis suggests that AP alternans is the
primary event in a series of events mechanistically linked to
arrhythmogenesis (19,60). Recently, this hypothesis was
further supported in a study by Pastore et al. (61) in
Langendorff-perfused guinea pig hearts; they were able to
show that increasing the pacing rate in the guinea pig
ventricle consistently induced concordant repolarization al-
ternans at a critical threshold heart rate, which led to the
development of discordant epicardial APD alternans and to
increased susceptibility to ventricular arrhythmias.
Though APD alternans may be the result of a wide
variety of cellular conditions (see section titled “Ionic
currents, calcium homeostasis and alternans”), at the whole-
heart level changes in the relationship between the APD
and the preceding diastolic interval (the restitution curve)
affect AP alternans. The mechanism by which APD alter-
nans could produce arrhythmias was clarified by Karma in
1993, (62) who showed that an APD restitution curve with
slope greater than 1 could produce wave-break (for defini-
tion, see Table 1) in spiral wave re-entry. By reducing APD
restitution steepness, in computer simulations Karma (62)
and Weiss et al. (63) showed that spiral wave breakup can be
prevented, and spiral wave behavior can be stabilized.
The mechanisms underlying induction of discordant
alternans in the heart are unknown; however, it has been
hypothesized that discordant alternans develops in structur-
ally normal myocardium where large heterogeneities in
cellular repolarization properties exist or in myocardium
with a structural barrier that causes cell-to-cell uncoupling
where minor heterogeneities exist (48). Discordant alter-
nans markedly increases dispersion of refractoriness and
increases the ability of a premature stimulus to cause
localized wavebreak and induce reentry, even in completely
Table 1. Electrophysiologic Definitions
APD: time to 90% repolarization of the action potential
APD restitution: APD dependence on previous diastolic interval
Wave: cardiac excitation is viewed as an electrical wave
Wavefront: corresponds to the action potential upstroke (phase 0)
Waveback: corresponds to rapid repolarization (phase 3)
Wavelength: the distance between the wavefront and the waveback
Wavebreak: the break of single waves of electrical activity into multiple
smaller waves
Concordant alternans: wavelengths of successive waves that alternate
between long and short
Discordant alternans: two spatially discrete sites exhibiting APD
alternans at opposite phases (Ref. 19)
APD  action potential duration.
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homogeneous tissue. Furthermore, it is logical to speculate
that factors known to modulate repolarization, such as
transient ischemia (19,64), myocardial scar (32), premature
ventricular depolarizations (61), or sympathetic stimulation
(65), may trigger discordant alternans.
TECHNICAL ASPECTS
The FFT spectral analysis. Several algorithms have been
developed to measure subtle beat-to-beat microvolt-level
alternans. The most widely used procedure, termed the FFT
spectral method, has been previously reported (32,66) and is
briefly summarized here. It utilizes the vector magnitude
ECG signal recorded from the three Frank orthogonal leads
over at least 128 ECG beats. Fourier analysis is used to
compute the power spectra of the beat-to-beat fluctuations
in the amplitudes of corresponding sample points of the
time-aligned QRST complexes. The power spectra corre-
sponding to sample points within a given section of ECG
complex (e.g., T-wave) are averaged. The presence of
alternans is indicated by the presence of a peak at the last
point in the averaged spectrum, corresponding to a fre-
quency of 0.5 cycles per beat (Fig. 1). The analysis yields
two measurements: the alternans magnitude (Valt) and the
alternans ratio (k). The Valt represents the magnitude of the
alternating variation in T-wave morphology compared to
the mean T-wave. The alternans ratio is a measure of the
statistical significance of the alternans compared to the
standard deviation of the background noise. One of the
inherent strengths of the FFT spectral method is its ability
to differentiate between true alternans and nonspecific noise
in the ECG.
A commercial instrument that can quantify microscopic
TWA has recently received Food and Drug Administration
approval as a noninvasive screening test to identify patients
at risk for SCD (8). Using this system, the criteria for the
interpretation of TWA tests have been reported by Bloom-
field and Cohen (8). A positive TWA test is the presence of
sustained alternans with an amplitude at least 1.9 V and k
 3.0 measured in a single-vector lead or two adjacent
precordial leads (k  3.0 is required in only one of the two
precordial leads). Alternans should be present for at least 1
min, including some period of artifact-free data, with an
onset either at the resting heart rate or at a heart rate 110
beats/min (heart rate refers to a 128-beat averaged heart
rate) during exercise (by means of treadmill or stationary
bike). Artifact-free data are characterized by a frequency of
ectopic beats 10%, and is collected when the stepping or
pedaling rate is not at one-half the heart rate, the respiratory
rate is not at one-fourth the heart rate, the heart rate is not
changing more rapidly than 30 beats/min, and RR interval
alternans of 2 ms is not present. A TWA test is usually
defined as negative if it does not meet the criteria for a
positive test and a maximum negative heart rate 105
beats/min is achieved (so-called A Rules). The maximal
negative heart rate is defined as the highest heart rate at
which at least 1 min of data is present without significant
alternans, a noise level 1.8 V in the vector magnitude
lead and with fewer than 10% ectopic beats. The test may
also be negative in patients who stop exercise due to fatigue
or symptoms with a maximal negative heart rate 105
beats/min provided that the maximal negative heart rate is
within 5 beats/min of the maximum heart rate and is 80
beats/min (B Rules). An indeterminate TWA test is a test
that does not meet the criteria for being classified as positive
or negative.
The sensitivity of TWA to predict the induction of
sustained ventricular tachyarrhythmias is improved, with
more than the typically used orthogonal X, Y, Z leads, but
this is at the expense of specificity (67).
Other methods. Besides the above-described FFT-based
spectral method, several other computerized methods have
been applied for detection and quantification of TWA, such
as autocorrelation techniques (68), complex demodulation (14)
and autoregression techniques (69). The motivation for devel-
oping these techniques is the desire to detect rapid changes in
alternans such as those observed during ischemia (65). Further
Figure 1. Representative example of power spectrum of beat-to-beat fluctuations in T-wave morphology. The alternans ratio is the amplitude of the
spectrum at the alternans frequency (alternans peak) minus the mean background noise level (noise), divided by the standard deviation of the noise (noise)
in the reference noise band plots. Reproduced with permission from Armoundas et al. (99).
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investigation is needed to show that these alternative methods
are equivalent to the FFT spectral method.
CLINICAL RESULTS
Importance of heart rate onset. Animal experiments have
demonstrated that under physiologic conditions a critically
short cycle length is required for induction of AP alternans
(70,71), and that the heart rate onset required to elicit
discordant alternans was significantly reduced in the pres-
ence of a structural barrier (48). Similarly in humans, a
number of studies indicate that the magnitude of TWA is
strongly dependent on heart rate (67,72–74), with an
optimal heart rate for measuring microvolt-level TWA
between 100 and 120 beats/min. However, interpretation of
the TWA test must also take into account the dynamic
variation of heart rate with exercise. For example, alternans
that occurs episodically and does bear a consistent relation-
ship to heart rate has not been associated with increased
arrhythmic risk.
It does not appear to matter whether the threshold heart
rate required to induce TWA is achieved by exercise or atrial
pacing. In a comparison of exercise- and pacing-induced
alternans, the average pacing rate at which TWA first
became positive was 99  9 beats/min, whereas the average
heart rate at which TWA became positive during exercise in
the same patients was 100  13 beats/min. This suggests
that it is the heart rate per se and not autonomic nervous
system tone changes that appear to be the main factor of
determining the onset of TWA (73). However, Hohnloser
et al. (73) showed that, in patients with sustained alternans,
the amplitude of alternans was greater at peak exercise than
at the corresponding heart rate during atrial pacing (exercise
TWA 11.4  7.3 V, right atrial pacing TWA 5.7 
1.8 V). This suggests that sympathetic activation present
at peak exercise modulates and tends to increase TWA, thus
potentially influencing the sensitivity of the test.
A number of studies have measured TWA in different
patient populations. Interpretation of these studies is com-
plicated by different statistical metrics used to describe the
changes in risk based on the outcome of the test. These
clinical studies are summarized in the following sections and
in Table 2.
TWA in patients at risk of VT/VF. The first human study
revealing a statistically significant relationship between the
outcome of EPS testing and the presence of repolarization
alternans was conducted in 1988 (32). In another study of
83 patients undergoing EPS testing, microvolt TWA was
correlated with inducibility of sustained VT or VF and
inversely correlated with 20-month arrhythmia-free survival
(Fig. 2) (66). A shortcoming of this study (66) was the
invasive method employed (right atrial pacing) for eliciting
TWA; nonetheless, a positive TWA test predicted arrhyth-
mic events with an accuracy equivalent to that of pro-
grammed ventricular stimulation.
T-wave alternans can be elicited and measured noninva-
sively during bicycle exercise testing (75,76). In a prospec-
tive study, Hohnloser et al. (76,77) compared various
conventional markers of arrhythmic risk in 95 high-risk
patients who had undergone ICD implantation. The patient
cohort comprised 75% with coronary artery disease, 17%
dilated cardiomyopathy, 2% hypertrophic cardiomypathy,
5% no heart disease and 1% other. The end point of this
Table 2. Clinical Studies on the Predictive Power of T-Wave Alternans to Sustained
Ventricular Tachyarrhythmias
Study
Patient
Population
End
Point
Indeterminate
Tests
Predictive
Power
Rosenbaum et al. (66)* EPS (n  83) VT/VF NA RR  5.2
Estes et al. (75)* EPS (n  51) VT/VF n  24 (47%) A  80%
Hohnloser et al. (76)* CAD, DCM, HCM
(n  95)
ICD discharge n  16 (18%) RR  2.5
CAD (n  71) RR  3.9
Ikeda et al. (83)* Post-MI (n  119) AE n  17 (14%) A  64%
RR  16.8
Gold et al. (78)* EPS (n  313) AE n  75 (24%) RR  10.9
Klingenheben et al. (82)* CHF (n  107) AE n  22 (21%) RR  
Adachi et al. (81)* DCM (n  58) VT n  10 (17%) A  77%
Hennersdorf et al. (80)† NICM (n  66) AE n  6 (9%) SENS  65%
SPEC  98%
Tapanainen et al. (84)* Post-MI (n  379) ACM n  178 (47%) NS
Ikeda et al. (91)* Brugada (n  33) VT/VF n  2 (6%) A  52%
Ikeda et al. (85)* Post-MI (n  834) AE n  95 (12%) RR  11.4
Kitamura et al. (74)* DCM (n  104) AE n  21 (20%) RR  7.4
*Prospective. †Retrospective.
A  accuracy; ACM  all-cause mortality; AE  arrhythmic event; CAD  coronary artery disease; DCM  dilated
cardiomyopathy; EPS  electrophysiologic study presumed for ventricular arrhythmias; HCM  hypertrophic cardiomyopathy;
MI  myocardial infarction; n  number of patients; NA  not applicable; NICM  nonischemic cardiomyopathy; NS 
nonsignificant; RR  relative risk; SENS  sensitivity; SPEC  specificity; VF  ventricular fibrillation; VT  ventricular
tachycardia.
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study (76) was the first appropriate ICD discharge docu-
mented by review of the stored electrograms. Forty-one
patients (43%) had at least one documented arrhythmic
event. Statistical analysis revealed that of the 10 risk markers
included in the model, only a positive TWA result and a
reduced LVEF were significant predictors of appropriate
ICD discharges both in the entire study population and in
the coronary artery disease subgroup. Notably, inducibility
during EPS testing failed to achieve statistical significance
in predicting appropriate ICD discharge.
In a prospective multicenter study of 313 patients, ven-
tricular arrhythmia risk was assessed in patients undergoing
EPS testing using TWA and signal-averaged electrocardi-
ography (SAECG) (78). The indication for EP testing in
this group was syncope or presyncope (41%), cardiac arrest
(5%), sustained VT (14%), nonsustained ventricular tachy-
cardia (NSVT) (4%) and supraventricular arrhythmias
(31%). The primary end points of this study (78) were SCD,
sustained VT, VF, appropriate ICD therapy or cardiac
arrest. A composite secondary end point of any ventricular
arrhythmia or all-cause mortality was also employed.
Follow-up was obtained in 290 patients (92.6%) with a
mean duration of 297  103 days. A total of 22 patients
experienced the primary end points, including 15 patients
with ICDs. The relative risk for experiencing a primary end
point was 10.9 for TWA, 7.1 for EPS testing and 4.5 for
SAECG. In 27 patients with secondary end points, the
relative risk (RR) was 13.9 for TWA, 4.7 for EPS testing
and 3.3 for SAECG. Cox regression analysis revealed that
TWA was the only independent statistically significant
predictor of events.
However, in a study of 95 patients referred for EPS
testing, the QT variability index was superior to TWA
(measured during right atrial pacing), monomorphic VT
inducibility at EPS study, SAECG, HRV and ejection
fraction in identifying patients with prior sudden death (79).
Univariate analysis reported that QT variability index was
predictive of arrhythmia-free survival; however, this analysis
was not reported for TWA (79).
TWA in cardiomyopathy. In a study of 60 patients with
idiopathic dilated cardiomyopathy but nearly normal
LVEF, 12 patients had positive TWA test (80). Ten of the
12 patients with positive TWA test had a prior ventricular
tachyarrhythmia, while significantly fewer (6 of 48) TWA-
negative patients experienced an arrhythmia. Three patients
developed ventricular tachyarrhythmic events during a six-
month follow-up period, and all had had a positive TWA
test.
In a study by Adachi et al. (81) of 58 patients with dilated
cardiomyopathy (DCM) (New York Heart Association
functional class: 1.6  0.8), TWA testing was positive in
23, negative in 25 and indeterminate in 10 patients. Anal-
ysis of a limited number of recorded ventricular arrhythmias
including NSVT (3 consecutive premature ventricular
beats, 14 episodes) or sustained VT (VT that lasted  30 s,
three episodes) revealed that ventricular arrhythmias were
more common in patients with a positive TWA test (the
sensitivity, specificity and predictive accuracy rates of TWA
to predict VT were 88%, 72% and 77%, respectively). Of
course, predicting the presence of ventricular arrhythmias in
a population with DCM is not a surrogate for predicting
overall mortality or even cardiac events.
A study of 104 patients with nonischemic DCM, with 12
arrhythmic events during 21  14 months of follow-up,
showed that TWA in a subgroup of patients with an onset
heart rate100 beats/min (compared to the standard TWA
heart rate onset) was the most significant predictor of
arrhythmia-free survival (sensitivity: 75%; specificity: 78.9%;
positive predictive value: 37.5%; negative predictive value:
94.9%; RR: 7.4). This is the first clinical study to elucidate
the prognostic value of the heart rate onset of TWA in
patients with DCM (74).
Figure 2. The relation between T-wave alternans and arrhythmia-free survival in 66 patients is shown in the left panel. Kaplan-Meier life table
arrhythmia-free survival compared patients with and without T-wave alternans. In the right panel, arrhythmia-free survival in patients with a positive
electrophysiologic (EPS) study is compared to survival in patients in whom ventricular arrhythmias were not induced in EPS study. Note that the predictive
values of EPS study and T-wave alternans are essentially indistinguishable in these plots. Reproduced with permission from Rosenbaum et al. (66).
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The prognostic value of noninvasively measured TWA
was tested in a prospective study of 107 consecutive patients
with congestive heart failure (New York Heart Association
functional class II or III) and no history of sustained
ventricular arrhythmias (82). During 18 months of follow-
up, 13 patients had an arrhythmic end point. Of these, seven
died suddenly, five had sustained VT, and one was resusci-
tated from VF. Additionally, three patients died from
presumed pump failure. The TWA results were positive in
52 patients (49%), indeterminate in 22 patients (21%) and
negative in 33 others (31%). Of the patients with an end
point, 11 had a positive and 2 had indeterminate TWA
results. There were no patients with a negative TWA result
that experienced an arrhythmic event or SCD. Multivariate
Cox regression analysis revealed that, of TWA, LVEF,
NSVT, baroreflex sensitivity, HRV and SAECG, TWA
was the only independent statistically significant predictor
of arrhythmic events at 18 months of follow-up. These
results suggest that TWA in patients with congestive heart
failure may identify patients at increased risk of future
cardiac events; however, this was based on a small number
of events. Perhaps as importantly, minimally symptomatic
patients with left ventricular dysfunction and a negative
TWA test appear to have a low risk of significant cardiac
events.
Studies of the role of TWA testing in patients with other
types of cardiomyopathy are more scarce. A recent study
demonstrated a positive TWA test in 61% of patients with
hypertrophic cardiomyopathy (HCM) and only in 31% of
patients with hypertensive left ventricular hypertrophy de-
spite a nearly identical left ventricular mass index. In a
subset of 12 HCM patients who underwent endomyocardial
biopsy, TWA was greater in patients with more severe
myofibril disarray and fibrosis, suggesting that the more
severe histological changes are associated with greater elec-
trical instability in the ventricular myocardium (59). How-
ever, no follow-up data or comparisons to other noninvasive
predictors were provided.
TWA in patients with prior myocardial infarction. At
present there are only a few studies regarding the prognostic
utility of TWA in patients with a prior myocardial infarc-
tion (MI). T-wave alternans testing was performed in 102
patients with recent MI (20  6 days after the MI) to test
the hypothesis that the combination of LPs on the SAECG
and TWA, as indices of depolarization and repolarization,
respectively, would yield a higher positive predictive value
for the risk of subsequent arrhythmic events than either test
alone (83). There were a total of 15 sustained ventricular
arrhythmic events, none of which were fatal. A positive
TWA test exhibited the highest sensitivity, RR and nega-
tive predictive value but the lowest specificity, positive
predictive value and predictive accuracy when compared to
SAECG, LVEF and various combinations of all three tests.
The main limitation of the study was the small number of
events analyzed; however, consistent with TWA testing in
other forms of structural heart disease, a negative test was
associated with low risk of arrhythmic events (83). Recently,
a larger cohort of 836 patients who underwent TWA testing
2.7  5.4 months after MI revealed that TWA predicted
sudden cardiac death or resuscitated VF with a risk hazard
of 11.4 (85). In this study (85) the sensitivity, negative
predictive value and risk hazard of TWA for predicting
death or VF were higher than LVEF, SAECG and the
presence of NSVT; however, the specificity and positive
predictive value were indeed worse.
In a study of 379 consecutive post-MI patients with
optimal medical management, sustained TWA was not
present in any one of the 26 patients who died in follow-up
(84). A number of variables, including an incomplete TWA
test, increased HF-QRS duration on SAECG, increased
QT dispersion, nondiagnostic baroreflex sensitivity and low
wall-motion index, predicted all-cause mortality (84). How-
ever, an incomplete TWA test is a nonspecific end point;
thus, the association with an increased RR of death is
difficult to interpret. The investigators (84) suggest that the
absence of sustained TWA in patients who subsequently
died might be attributed to proximity of TWA testing to
the MI (8.1 days vs. an optimal time of a few weeks later)
or the high percentage of patients taking beta-blockers
(97%) compared with other studies such as that by Ikeda et
al. (83). However, the mortality rate after MI decreases with
time, and any test that fails to predict SCD soon after
infarction is limited in utility. If beta-blockers, the only
agents known to reduce mortality post-MI, interfere with
the predictive value of TWA testing, this represents a
limitation in the largest population at risk for SCD. How-
ever, TWA is not a predictor of all-cause mortality (84) as
the phenomenon reflects electrical instability associated
with arrhythmic events and SCD.
These studies (83–85) suggest that the timing of TWA
testing with respect to the MI is important. However, if a
positive TWA test takes a long time to evolve, its utility may
be limited immediately after the MI, the time when the risk
for life-threatening arrhythmias and death is greatest. In
summary, the utility of TWA testing for prognosis in
patients with recent MI needs to be further clarified.
TWA in patients with the long QT and the Brugada
syndromes. Macroscopic TWA has been observed in pa-
tients with idiopathic long QT syndrome (27,28,68,86–90).
Prolongation and lability of the ventricular AP and QT
interval, resulting from a reduction in repolarizing reserve,
may reflect the presence of the EP substrate that predisposes
to alternation of the QT interval and T-wave as well as to
the polymorphic VT known as torsade de pointes. The
prognostic value of microscopic TWA has not been assessed
in patients (or their relatives) with congenital or acquired
forms of the long QT syndrome, although case reports of
the existence of microscopic TWA have appeared (27).
The existence of TWA in other inherited arrhythmias
critically depends on the nature of the electrophysiologic
substrate. In patients with presumed Brugada syndrome,
TWA was no more frequent than in matched controls
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(normal subjects), whereas LPs on the SAECG were
significantly more frequent in patients compared to controls,
suggesting that conduction disturbances may be the primary
arrhythmogenic factor in patients with the Brugada syn-
drome (91). Obviously, the role of TWA testing in other
inherited arrhythmias (e.g., arrhythmogenic right ventricu-
lar dysplasia) remains unexplored.
Effects of antiarrhythmic treatment. Because antiarrhyth-
mic drug treatment may alter markers of risk, it would be
important to know how antiarrhythmic drug therapy influ-
ences TWA. Procainamide (92), amiodarone (93) and
beta-blockers (94,97,98) were reported on average to reduce
the amplitude of TWA, whereas flecainide (95) tended to
increase alternans.
In a published case report, dl-sotalol administration led to
the conversion of a negative TWA test to positive in the
setting of excessive prolongation of the QT interval (96).
Recently, Klingenheben et al. (97) reported 54 patients with
documented or suspected malignant ventricular tachyar-
rhythmias who underwent TWA testing and in whom the
acute administration of metoprolol and dl-sotalol reduced
overall TWA amplitude by 35% and 38%, respectively.
Eight patients (five in the metoprolol group and three in the
dl-sotalol group) became TWA negative after short-term
administration of the drugs. Notably, the patients who
became negative had a lower Valt in the drug-free state
compared to those patients who remained positive. This
study indicates that TWA is modulated—at least in some
patients—by sympathetic activity (97). The interpretation
of the effect of beta-blockers on the clinical utility of TWA
is complicated by at least two factors: blunting the chrono-
tropic response to exercise, which may prevent some pa-
tients from reaching the specific TWA threshold heart rate,
thus leading to an indeterminate test (84), and reducing the
magnitude of Valt (97). An unanswered question is whether
the beta-blocker-induced reduction in Valt is associated with
a reduced risk of sudden death. The reduction in Valt in
patients treated with dl-sotalol suggests the unproven pos-
sibility of using TWA testing to guide therapy with class III
antiarrhythmic drugs to minimize the risk of proarrhythmia.
Because dl-sotalol has both beta-blocking (class II) and class
III effects, such a study might be better suited to a drug with
more pure AP prolongation.
In a recent study (98), selective autonomic blockade
indicated that esmolol led to a statistically significant
reduction of TWA (measured during atrial pacing) com-
pared with a baseline measurement in 20 patients, whereas
the number of positive TWA tests in the same patients was
reduced by 50%. In the same study (98) parasympathetic
blockade with atropine in 20 patients did not cause any
change in the level of TWA compared with a baseline
measurement.
Applicability of TWA testing. Several experimental and
clinical studies have shown excellent reproducibility of
TWA determined by the FFT spectral method (32,97).
Thus far there have been only limited direct comparisons of
TWA with other noninvasive measures of risk stratification,
and a clear problem is that competitive tests have well-
documented limitations as risk stratifiers. Both SAECG
and measures of QT dispersion were either not statistically
significant predictors of arrhythmic risk or were inferior to
TWA testing (78,85,99,100). Similar results were obtained
by Hohnloser et al. (76) in an exercise-induced TWA study
as a predictor of EPS testing. However, in contrast to
SAECG, which is usually assessed in the time domain,
TWA testing can also be applied in patients with bundle
branch block (99). Historically, other noninvasive risk
stratifiers, such as LVEF, HRV, SAECG and NSVT on
Holter monitoring, have individually tended to show mod-
erately high sensitivity in a post-MI patient population, but
rather low positive predictive value (101). Such comparisons
with TWA must be made very cautiously, however, when
testing is not performed on the same patient populations.
The predictive accuracy of arrhythmic events using a
combined TWA and SAECG test was modestly better than
TWA alone in a retrospective study of patients who
underwent EPS testing for severe ventricular arrhythmias
(78,99). However, when the combined effect of TWA and
SAECG was examined in a larger population of patients
with prior MI, SAECG appeared to have no additive
prognostic power (85). It seems reasonable that TWA,
which is a measure of repolarization, may contain different
information, with respect to ventricular susceptibility to
arrhythmias, than SAECG, which is an index of ventricular
depolarization. Furthermore, one might expect nonoverlap-
ping information in TWA and SAECG because TWA is a
measure of beat-to-beat variability, whereas SAECG is a
measure of mean QRS morphology. Conversely, the com-
bination of TWA and LVEF increased the predictive power
of TWA in patients with prior MI (85), and nonischemic
DCM (74).
Limitations on the use of TWA testing. Although TWA
assessed during exercise testing correlates well with mea-
surement of TWA during atrial pacing, there are differences
and potential pitfalls in measuring TWA during cycling
(102). These limitations are both technical, including con-
trol of the patient’s pedaling rate and meticulous skin
preparation to improve signal-to-noise ratio, and biological,
including differences in the activation of the sympathetic
nervous system with exercise compared to pacing at similar
rates.
Exercise-based TWA testing is particularly appealing
because of its noninvasive nature, but it may be impossible
in specific subgroups of patients who are not able to perform
bicycle or treadmill testing, thus resulting in an indetermi-
nate test (Table 2). In such cases, pharmacological stress
testing using atropine or dopamine may be an alternative
approach for TWA assessment.
In Table 2, we have included the number of indetermi-
nate tests in patients for each study. This number includes
all possible reasons for indeterminate TWA testing, such as
the inability to achieve an adequate heart rate, excess noise,
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frequent atrial or ventricular ectopy or atrial arrhythmias.
However, the indeterminate rate of TWA testing may be
reduced by prolonging the exercise protocol to reduce the
likelihood that intermittent noise or ectopic beats will
obscure the TWA data, by efforts to reduce noise, and by
developing algorithms that enable one to measure alternans
in the presence of a higher level of ectopy. It is anticipated
that, by implementing these improvements, reported inde-
terminacy rates should decrease. Furthermore, the indeter-
minate rates are highly population dependent; they tend to
be highest in patients with the lowest LVEF.
Atrial fibrillation and other frequent arrhythmias, such as
frequent atrial and/or ventricular premature beats, limit the
use of TWA testing, as they do in other noninvasive
electrocardiographically based noninvasive tests that have
been employed as risk stratifiers.
PERSPECTIVES
A major challenge, which is also the focus of a number of
ongoing large clinical trials, is the prevention of SCD in
patients with structural heart disease. Invasive testing (e.g.,
EPS testing) is impractical and has limited predictive
power; noninvasive testing methods thus far lack specificity
and predictive power. Implantation of defibrillators in all
those at risk will place an unmanageable economic burden
on the health care system. Refinement of selection criteria
for patients who require the most aggressive therapy for
sudden death prevention is as yet an elusive goal.
The clinical utility of TWA in predicting SCD appears
promising, although still unproven, for patients with; 1)
symptoms suggestive of ventricular arrhythmias (78); 2)
congestive heart failure or ejection fraction 40% (74,82);
and 3) a recent MI (TWA testing should be performed
three to six weeks post-MI) (85). Because TWA has an
excellent negative predictive value, patients who have a
negative TWA test are at low risk for ventricular arrhyth-
mias and SCD, whereas patients who test positive may be at
significant risk and should be considered for invasive testing
and prophylactic treatment.
T-wave alternans testing has shown promise as a nonin-
vasive predictor of potentially lethal ventricular arrhythmias
in initial studies of diverse patient populations with struc-
tural heart disease. The ultimate role of TWA testing in the
armamentarium of noninvasive predictors of mortality
awaits further large-scale prospective testing. Future studies
should address the reproducibility of TWA, the effective-
ness of ICD therapy using TWA testing in patients with a
negative EPS test, the role of TWA in guiding therapy with
beta-blockers, angiotensin-converting enzyme inhibitors,
aldosterone antagonists and antiarrhythmic drugs.
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